New drug duo tested for Tough-to-Treat lung cancer

NCT ID NCT07037758

Recruiting now Disease control Sponsor: Amgen Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety and best dose of a two-drug combination (tarlatamab and AB248) for people with extensive stage small cell lung cancer that has worsened after at least one prior treatment. The main goal is to see how well the body handles the drugs together and to check for side effects. Researchers will also look for early signs that the treatment might help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Adana Sehir Egitim ve Arastirma Hastanesi
RECRUITING

Adana, 01370, Turkey (Türkiye)
Allegheny General Hospital
RECRUITING

Pittsburgh, Pennsylvania, 15212, United States
Ankara Bilkent Sehir Hastanesi
RECRUITING

Ankara, 06800, Turkey (Türkiye)
Avera Cancer Institute
RECRUITING

Sioux Falls, South Dakota, 57105, United States
Baptist Cancer Center
RECRUITING

Memphis, Tennessee, 38120, United States
Chungbuk National University Hospital
RECRUITING

Cheongju Chungbuk, 28644, South Korea
Dana-Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02215, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Hacettepe Universitesi Tip Fakultesi Hastanesi
RECRUITING

Ankara, 06230, Turkey (Türkiye)
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
Norton Cancer Institute - Downtown
RECRUITING

Louisville, Kentucky, 40202-1703, United States
Seoul National University Bundang Hospital
RECRUITING

Seongnam-si, Gyeonggi-do, 13620, South Korea
Severance Hospital Yonsei University Health System
RECRUITING

Seoul, 03722, South Korea
Sidney Kimmel Cancer Center
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Siteman Cancer Center
RECRUITING

St Louis, Missouri, 63110, United States
Swedish Cancer Institute Medical Oncology
RECRUITING

Seattle, Washington, 98109, United States
University of Southern California, Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States

Conditions

Explore the condition pages connected to this study.

EXTENSIVE STAGE SMALL CELL LUNG CANCER